D-1364-2020 Class II Terminated

Recalled by Preferred Pharmaceuticals, Inc. — Anaheim, CA

Recall Details

Product Type
Drugs
Report Date
July 8, 2020
Initiation Date
June 17, 2020
Termination Date
March 21, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
144 bottles

Product Description

Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc., Farmingdale, NY, Preferred Pharmaceuticals, Anaheim, CA NDC: 68788-6932-01

Reason for Recall

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Distribution Pattern

Product was distributed to two medical clinics located in FL.

Code Information

J0119M, K1419L, K2719J, A0220H; Exp. Date 12/2020